Current Opinion in Molecular Therapeutics

Published by: Thomson Reuters  

People

  1. Sadelain
    Sadelain

Groups

  1. Center for Hematologic Malignancies (1)
  2. Department of Medicine (1)
  3. GSK Faculty (1)
  4. Hematologic Malignancies Research (1)
  5. Hematologic Malignancies, Division of (1)
  6. Molecular Pharmacology and Chemistry Program Faculty (1)
  7. Sloan Kettering Institute Faculty (1)

Current Opinion in Molecular Therapeutics – authorized name for:

Name ISSN / ISBN Publisher
Current Opinion in Molecular Therapeutics 1464-8431 Thomson Reuters
Current Opinion in Molecular Therapeutics 1464-8431 Thomson Reuters
Current Opinion in Molecular Therapeutics 14648431 Thompson Current Drugs
Current Opinion in Molecular Therapeutics 1464-8431 Pharmapress Ltd
Current Opinion in Molecular Therapeutics 14648431 The Thomson Corporation
Current Opinion in Molecular Therapeutics 1464-8431 Current Drugs Ltd
Current Opinion in Molecular Therapeutics 14648431 Unknown